Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Soft tissue structure refers collectively to the tissues in the body that are not hardened by calcification (bone) or lined by epithelium. This includes muscle tissue, tendons, ligaments, fibrous tissue, fasciae, fat (adipose tissue), synovial membranes, blood vessels, and peripheral nerves. These tissues are composed primarily of collagen, elastin, and other components of the extracellular matrix, and are populated by various mesenchymal cell types such as fibroblasts, chondrocytes, adipocytes, and peripheral nerve cells. Soft tissues provide physical support, flexible strength, protection for organs, transmission of mechanical forces, and contribute to repair and structural integrity. They are essential to mobility, vascular health, organ stability, wound healing, and energy storage. Disease processes in soft tissue include injuries, fibrotic conditions, and tumors such as soft tissue sarcomas.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Soft tissue structure.